Equity Overview
Price & Market Data
Price: $1.07
Daily Change: +$0.02 / 1.87%
Daily Range: $1.00 - $1.07
Market Cap: $8,841,457
Daily Volume: 203,695
Performance Metrics
1 Week: -13.45%
1 Month: -20.77%
3 Months: -39.05%
6 Months: -48.50%
1 Year: -79.52%
YTD: -76.32%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.